Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Search for Articles
Feb 28, 2022
Feb 14, 2022
Broadview Ventures 2021 Annual Report
We are pleased to report another robust year of activities in 2021, with several new...
Feb 9, 2022
HAYA Therapeutics Establishes U.S. Location
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target...
Feb 4, 2022
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
Dublin, Ireland, 4 February 2022 – CroíValve, a Dublin based medical device company developing a...
Jan 24, 2022
Puzzle Medical Devices Inc. announces the closing of its major Seed financing round to support its first-in-human study
MONTREAL, January 24, 2022 /PRNewswire/ – Montreal based Puzzle Medical Devices Inc., a medical device...
Dec 9, 2021
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
NEW HAVEN, Conn. and NANJING, China, Dec. 9, 2021 /PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics,...